Moreover, overexpression of decorin protected endothelial function from hyperglycemia and promoted angiogenesis through IGF1R/AKT/AP-1/VEGF signaling, suggesting that decorin could be a new therapeutic strategy for patients suffering from DCM. This evidence concerns the gene AKT1 and Hyperglycemia.